Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Mycoses ; 54(5): e377-83, 2011 Sep.
Article in English | MEDLINE | ID: mdl-20609085

ABSTRACT

Treating patients with multiple oral leucoplakias (MOLs) who smoke is more difficult and complicated than treating those with single oral leucoplakia (SOL). Removing the aetiological factors causing MOL can effectively prevent its recurrence. The aim was to study the infection by and influences of Candida in smoking patients with MOLs. A retrospective study was conducted on 136 smoking patients who had clinicopathological OLs. Among these patients, 73 lesions in 31 patients were MOLs, while 105 patients had SOLs. All patients were treated by complete resection. All specimens were tested for epithelial dysplasia, and stained with periodic acid-Schiff reagent. The rate of MOL concurrence with candidal infection was higher than that of SOLs. The incidence of Candida associated with MOLs was higher for recurrent than for non-recurrent lesions. The disease-free time was shorter in MOL patients with candidal infection. Moreover, MOLs with candidal infection were more likely to have an increasing ratio to combine with epithelial dysplasia. Candida is an important risk factor in smoking patients with MOLs. Microscopic and fungal examinations of those lesions should permit a detailed diagnosis in such patients and for long-term predictive assessments.


Subject(s)
Candida/isolation & purification , Candidiasis/epidemiology , Leukoplakia/complications , Smoking/adverse effects , Female , Humans , Incidence , Leukoplakia/surgery , Male , Retrospective Studies
2.
Kaohsiung J Med Sci ; 26(6): 299-307, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20538234

ABSTRACT

Existing therapies for symptoms related to painful clicking of the temporomandibular joint (TMJ) have rarely met with complete success and predicting prognosis remains difficult. Few studies have reported the efficacy of maxillary flat occlusal splints (MFOSs) for the treatment of painful clicking of the TMJ, and few studies have evaluated the predisposing factors that influence the clinical outcomes of MFOSs. The aim of this study was to investigate the treatment efficacy of MFOSs for painful clicking of the TMJ, and to determine the factors influencing TMJ therapy with MFOSs. We conducted a retrospective study of 109 patients suffering from unilateral clicking concurrent with preauricular area pain for at least 2 months between 2004 and 2008. Seventy-five patients were treated with an MFOS, while 34 patients did not receive MFOS therapy. Clicking score, pain-free maximal mouth opening, pain score, duration of the clicking sounds, age and bruxism were recorded during treatment and involved into the reviews. The degree of joint clicking was determined by a stethoscope placed in the anterolateral area of the external auditory canal and was divided into four grades. Data were analyzed using a Mann-Whitney U test, Fisher's exact test, and Student's t test. Results showed statistically significant differences in treatment outcomes between the MFOS-treated and control groups in clicking index, maximal mouth opening, pain and complete remission rates of symptoms within 1 year. Furthermore, for patients treated with MFOS, there were statistically significant differences in the clinical outcomes between those with a high clicking index and those with a low index before treatment. Factors significantly correlated with successful outcomes of MFOS included nocturnal bruxism, patient age and duration of clicking. MFOSs can be used to treat patients with painful clicking of the TMJ and related symptoms. The severity of clicking, bruxism, age and duration of clicking are all important factors influencing treatment outcomes with MFOSs.


Subject(s)
Occlusal Splints , Pain Management , Temporomandibular Joint Disorders/therapy , Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Retrospective Studies , Temporomandibular Joint/physiopathology , Temporomandibular Joint Disorders/physiopathology , Treatment Outcome , Young Adult
3.
J Oral Maxillofac Surg ; 68(5): 1055-63, 2010 May.
Article in English | MEDLINE | ID: mdl-20403529

ABSTRACT

PURPOSE: To offer recommendations of risk factors, prevention, and treatment of oral bisphosphonate and steroid-related osteonecrosis of the jaw (BSRONJ) in Taiwan. MATERIALS AND METHODS: Twelve patients were clinicopathologically proved to have bisphosphonate-related osteonecrosis of the jaw (BRONJ). All of the patients were taking oral bisphosphonates and were concurrently administered long-term steroids. Of the 12 patients, 3 patients were assigned to the first stage of BRONJ; 5 patients were assigned to the second stage, and 4 patients were assigned to the third stage. The patients' symptoms, localization of necrosis, presence of a fistula, and association with possible triggering factors for onset of the lesion were recorded. RESULTS: The radiologic investigations revealed osteolytic areas and scintigraphy demonstrated increased bone metabolism. Microbiologic analysis showed pathogenic actinomycosis organisms in a majority of patients (91.6%). Antibiotic therapy, minor debridement surgery, and combined hyperbaric oxygen therapy were useful in obtaining short-term symptomatic relief. CONCLUSIONS: Comorbidities of steroid use along with bisphosphonates may cause osteonecrosis of the jaw to occur sooner, be more severe, and respond more slowly to a drug discontinuation. The clinical disease of BSRONJ is more severe and more unpredictable to treat than BRONJ. From the data gained from other published studies of BRONJ and our clinical experience with the series of cases of BSRONJ, we offer recommendations of risk factors, prevention, and treatment of BSRONJ in southern Taiwan.


Subject(s)
Bone Density Conservation Agents/adverse effects , Diphosphonates/adverse effects , Glucocorticoids/adverse effects , Jaw Diseases/chemically induced , Osteonecrosis/chemically induced , Actinomycosis/complications , Administration, Oral , Aged , Aged, 80 and over , Alendronate/administration & dosage , Alendronate/adverse effects , Anti-Bacterial Agents/therapeutic use , Bone Density Conservation Agents/administration & dosage , Debridement , Diphosphonates/administration & dosage , Follow-Up Studies , Glucocorticoids/administration & dosage , Humans , Hyperbaric Oxygenation , Jaw Diseases/classification , Jaw Diseases/microbiology , Jaw Diseases/therapy , Mandibular Diseases/chemically induced , Mandibular Diseases/therapy , Maxillary Diseases/chemically induced , Maxillary Diseases/therapy , Middle Aged , Osteolysis/chemically induced , Osteolysis/therapy , Osteonecrosis/classification , Osteonecrosis/microbiology , Osteonecrosis/therapy , Osteosclerosis/chemically induced , Osteosclerosis/therapy , Risk Factors , Taiwan , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...